Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05720702 · ClinicalTrials.gov registry record · Early Phase 1
A Feasibility Trial of OCM Supplements for the Treatment of NAFLD
A Early Phase 1 study, sponsored by Duke University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 31
- Enrollment target
NCT05720702 is a Early Phase 1 study that has completed, run by Duke University. The registered enrollment target is 31 participants.
The verdict
NCT05720702, a Early Phase 1 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the feasibility of a trial to test the effects of homocysteine (Hcy) lowering supplements in patients with NAFLD. NAFLD patients will be asked to take Hcy lowering supplements (Vitamin B12, Folate, Vitamin B6, and Betaine) daily for 12 weeks. Over the course of approximately 12 to 13 weeks, participants will complete two in person visits and two phone visits to complete activities such as physical exam, fibroscan, blood draws, and questionnaires.
Interventions
- DIETARY_SUPPLEMENT homocysteine (Hcy) lowering supplements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2023-06-30 |
| Est. Completion | 2024-08-23 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05720702
The ClinicalTrials.gov registry entry for NCT05720702 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which homocysteine (Hcy) lowering supplements is the first listed.
NCT05720702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05720702 about?
NCT05720702 is a clinical study titled "A Feasibility Trial of OCM Supplements for the Treatment of NAFLD". The purpose of the study is to assess the feasibility of a trial to test the effects of homocysteine (Hcy) lowering supplements in patients with NAFLD. NAFLD patients will be asked to take Hcy lowering supplements (Vitamin B12, Folate, Vitamin B6, and Betaine) daily for 12 weeks. Over the course of...
What is the current status of trial NCT05720702?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 31 participants. The study started on 2023-06-30. Estimated completion is 2024-08-23.
What interventions are being tested in trial NCT05720702?
The interventions under investigation include: homocysteine (Hcy) lowering supplements (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05720702?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.